A radioimmunoassay combined with solid-phase extraction for the determination of a novel anti-obesity agent, ARL 15849XX, in dog plasma.
A radioimmunoassay has been developed for the determination of ARL 15849XX, a cholecystokinin-8 (CCK-8) analogue, in dog plasma. The method incorporates solid-phase sample extraction and is suitable for the determination of the analyte at picogram per millilitre concentrations. The antiserum was raised in Suffolk-cross sheep following primary and booster immunisations with an immunogen prepared by conjugating ARL 16935XX, an analogue of ARL 15849KF, to bovine serum albumin. The radioligand was prepared by the no-carrier-added 125I iodination of a non-sulphated derivative, ARL 15745XX. The solid-phase extraction procedure, carried out using ion-exchange aminopropyl and octadecyl sorbents sequentially, was introduced to remove matrix interferences in the plasma and to enhance the method sensitivity. The calibration range is 20-1000 pg ml-1, using a 1 ml sample of undiluted dog plasma.
Willson
V J
VJ
Department of Physical Chemistry, Astra Charnwood, Loughborough, Leics., UK.
Preston
J R
JR
Lockley
W J
WJ
Singh
J
J
Wilkinson
D
D
D000595:Amino Acid Sequence; D000818:Animals; D002138:Calibration; D002623:Chemistry Techniques, Analytical / Q000379:methods; D002766:Cholecystokinin / Q000031:analogs & derivatives* / Q000097:blood; D003429:Cross Reactions; D004285:Dogs; D004355:Drug Stability; D008969:Molecular Sequence Data; D009765:Obesity / Q000188:drug therapy*; D011863:Radioimmunoassay; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000819:agonists; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
C101320:ARL 15849XX; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin